Drugs

MindHere’s a look into Silicon Valley’s ‘executive psychedelic slumber parties’ that cost over $3,000
By Ani FreedmanFebruary 18, 2025

By Lindsey LeakeFebruary 14, 2025

PoliticsCanada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs
By The Associated PressFebruary 12, 2025

By Lindsey LeakeFebruary 6, 2025

CommentaryThe faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By Jeffrey Sonnenfeld and Steven TianFebruary 5, 2025

HealthPatients will pay more for prescription meds and face drug shortages amid Trump tariffs, pharma groups warn
By Lindsey LeakeFebruary 5, 2025

HealthPfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By Hallie SteinerFebruary 4, 2025

By Hallie SteinerFebruary 4, 2025

By Bloomberg and Damian GardeFebruary 4, 2025

HealthInvestors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By Ryan HoggFebruary 4, 2025

By Lindsey LeakeFebruary 3, 2025

HealthHims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025

By Bloomberg and Gerry SmithJanuary 31, 2025

By Bloomberg and John TozziJanuary 30, 2025
Most Popular



